BPH Development, Progression Linked to Sleep Problems
Findings emerged from an analysis of data from 2588 men who participated in the REDUCE trial.
Diagnosis & Disease Information
Blacks More Likely to Die From Metastatic Bladder Cancer
In a study, 2-year survival rates were 14.4% for whites compared with 6.5% for blacks.
Nomogram Developed to Predict Ureteral Stone Passage
Likelihood of stone passage in patients on medical expulsive therapy is based on variables such as stone size and location and white blood cell count.
Stone Formation Linked to Hemoglobin A1c Levels
Finding could explain the association between obesity and diabetes and the development of kidney stones.
Recurrence of Low-Risk RCC Uncommon After Surgery
In a study, the 5-year risk of recurrence was 4.8%, 18.1%, and 46.3% for patients with low-, intermediate-, and high-risk disease.
Prostate Cancer Active Surveillance Does Not Up Metastasis Risk
Study finds no difference in metastasis-free survival observed after 15 years compared with radiation therapy or radical prostatectomy.
Bladder Surgery Complications Predicted by New Model
Nomograms specific to radical cystectomy currently do not exist to aid stratification of a patient’s risks for complications.
Biologics Combo Shows Promise As First-Line mRCC Therapy
In a phase 2 trial, atezolizumab plus bevacizumab improved PFS versus sunitinib in patients with renal cell carcinoma expressing PD-L1.
Sunitinib Dose Escalation May Benefit mRCC Patients
Added progression-free survival and prolonged overall survival possible, according to investigators.
Kidney Cancer Brain Metastases Not On the Rise
Researchers develop a model to predict which patients are more likely to harbor brain metastases at cancer diagnosis.
- Loading...
Loading...
Next post in Genitourinary Cancers Symposium
Loading... 
Loading...